RANDOMISED DOUBLE-BLIND PHASE III TRIAL OF CEDIRANIB (AZD 2171) IN RELAPSED PLATINUM SENSITIVE OVARIAN CANCER: RESULTS OF THE ICON6 TRIAL.
Conferences
-
- Overview
-
- Research
-
- Additional Document Info
-
- View All
-
Overview
status
publication date
has subject area
published in
Research
keywords
-
Life Sciences & Biomedicine
-
Obstetrics & Gynecology
-
Oncology
-
Science & Technology
Additional Document Info